&nbsp;

Sep 2022

Drug

bosutinib

Other Name(s): Bosulif®

Quick Link(s):

Nov 2024

Drug

oBINutuzumab

Other Name(s): Gazyva®

Quick Link(s):

May 2022

Drug

ceritinib

Other Name(s): Zykadia™

Quick Link(s):

Nov 2024

Drug

idelalisib

Other Name(s): Zydelig™

Quick Link(s):

Feb 2022

Drug

cobimetinib

Other Name(s): Cotellic™

Quick Link(s):

Nov 2024

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria

Drugs Used:

lenalidomide

Quick Link(s):

Regimen Monograph

May 2022

Regimen

MVAC(HD)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

BORT

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Relapsed or Refractory Multiple Myeloma

ODB - General Benefit

dexamethasone

Drugs Used:

bortezomib,

dexamethasone

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

TMXF

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

tamoxifen

Drugs Used:

tamoxifen

Quick Link(s):

Regimen Monograph

May 2022

Regimen

PACL

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

PACLitaxel

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

PACL

Cancer Type:

Sarcoma,

Kaposi's Sarcoma

Intent: Palliative

Drugs Used:

PACLitaxel